Newly approved drug effective against lung cancer caused by genetic mutation
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial. The drug is designed to shut down the effects of the mutation, which is found in about 13% of patients with […]
Personalized cancer vaccines for breast, pancreatic cancers show promise
Researchers at Washington University School of Medicine in St. Louis have shown that personalized cancer vaccines made using DNA…
Cell-based immunotherapy shows promise against melanoma
A new study from Washington University School of Medicine in St. Louis demonstrates, in mice and human cells, that a cell-based…